Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Magainin awarded SBIR Grant for development of asthma therapy

Sep. 1, 2000

Neutrophil elastase inhibitors may actually target an important host defense enzyme

Sep. 1, 2000

Asthma research at Bayer targets inhibition of MMP

Aug. 31, 2000

Aventis reports MMP-12 inhibitors for the treament of emphysema in smokers

Aug. 31, 2000

Rigel and Novartis establish drug discovery agreement for respiratory therapies

Aug. 29, 2000

Vitamin D3 derivatives claimed by Teijin for treatment of cystic fibrosis

Aug. 29, 2000

Potent, selective muscarinic M3 receptor antagonists patented by Mitsubishi-Tokyo

Aug. 29, 2000

FDA approves Advair Diskus for treatment of asthma

Aug. 28, 2000

Neurokinin antagonists under development for treatment of respiratory diseases

Aug. 28, 2000

Theratechnologies to commence phase II trial of ThGRF1-44 in COPD

Aug. 25, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...